Latest Breaking News On - Chad messer needham company analyst - Page 1 : comparemela.com
Cytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Operator
Good day. Thank you for standing by, and welcome to the G1 Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions]
I would now like to turn the conference over to your host, Mr. Will Roberts. Please go ahead, sir.
William Roberts
Vice President of Investor Relations & Corporate Communications
Thank you, Sarah. Good afternoon, everyone, and welcome to the G1 conference call to discuss our second quarter 2021 financial results and business update. The press release on these financial results was issued after market closed this afternoon and can be found in the News section of our corporate website, G1therapeutics.com. On this call, the team will provide a business overview of the second quarter of 2021, including an update on our launch progress in that period with COSELA which was
Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
Esperion Therapeutics Inc (NASDAQ: ESPR)
Popular Searches
Operator
Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today s conference call may be recorded. I would now like to hand the conference call over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our
vimarsana © 2020. All Rights Reserved.